Variable gene family usage of protective and non-protective anti-Vibrio cholerae O1 LPS antibody heavy chains

Microbiology and Immunology

Volumn 52, Issue 12, 2008, Pages 611-620

  Wade, Terri K ^a   Wade, William F ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cholera; Lipopolysaccharide (LPS); Monoclonal antibody; Variable region

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; VIBRIO CHOLERAE ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; HEAVY CHAIN; HYBRIDOMA CELL CULTURE; IMMUNIZATION; LIGHT CHAIN; MOUSE; NONHUMAN; SOMATIC MUTATION; VIBRIO CHOLERAE; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; CHOLERA; GENETICS; HUMAN; HYBRIDOMA; IMMUNOLOGY; MICROBIOLOGY; MOLECULAR GENETICS; SEQUENCE ALIGNMENT;

ANIMALIA; MUS; VIBRIO CHOLERAE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA; FEMALE; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN HEAVY CHAINS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; VIBRIO CHOLERAE O1;

EID: 59449092263     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00078.x     Document Type: Article

References (25)

1. Provenzano D., Kováč P., Wade W.F. (2006) The ABCs (Antibody, B cells, and Carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine. Microbiol Immunol 50: 899-27.
2. Mukhopadhyay S., Nandi B., Ghose A.C. (2000) Antibodies (IgG) to lipopolysaccharide of Vibrio cholerae O1 mediate protection through inhibition of intestinal adherence and colonisation in a mouse model. FEMS Microbiol Lett 185: 29-35.
3. Tacket C.O., Forrest B., Morona R., Attridge S.R., LaBrooy J., Tall B.D. et al. (1990) Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect Immun 58: 1620-7.
4. Mosley W.H., Woodward W.E., Aziz K.M., Rahman A.S., Chowdhury A.K., Ahmed A. et al. (1970) The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. J Infect Dis 121: 1-9.
5. Mosley W.H., Aziz K.M., Rahman A.S., Chowdhury A.K., Ahmed A. (1973) Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh-three years of observation. Bull World Health Organ 49: 381-87.
6. Mosley W.H., Ahmad S., Benenson A.S., Ahmed A. (1968) The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bull World Health Organ 38: 777-85.
7. Mosley W.H., Benenson A.S., Barui R. (1968) A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the immunized and control population of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate. Bull World Health Organ 38: 335-46.
8. Benenson A.S., Mosley W.H., Fahimuddin M., Oseasohn R.O. (1968) Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field. Bull World Health Organ 38: 359-72.
9. Gupta R.K., Szu S.C., Finkelstein R.A., Robbins J.B. (1992) Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin. Infect Immun 60: 3201-208.
10. Chernyak A., Kondo S., Wade T.K., Meeks M.D., Alzari P.M., Fournier J.M. et al. (2002) Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier. J Infect Dis 185: 950-62.
11. Meeks M.D., Saksena R., Ma X., Wade T.K., Taylor R.K., Kováč P. et al. (2004) Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies. Infect Immun 72: 4090-101.
12. Saksena R., Ma X., Wade T.K., Kováč P., Wade W.F. (2005) Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa. Carbohydr Res 340: 2256-69.
13. Saksena R., Ma X., Wade T.K., Kováč P., Wade W.F. (2006) Length of the linker and the interval between immunizations influences the efficacy of Vibrio cholerae O1, Ogawa hexasaccharide neoglycoconjugates. FEMS Immunol Med Microbiol 47: 116-28.
14. Wade T.K., Saksena R., Shiloach J., Kováč P., Wade W.F. (2006) Immunogenicity of synthetic saccharide fragments of Vibrio cholerae O1 (Ogawa and Inaba) bound to Exotoxin A. FEMS Immunol Med Microbiol 48: 137-51.
15. Wade W.F. (2006) B-cell responses to lipopolysaccharide epitopes: Who sees what first - does it matter? Am J Reprod Immunol 56: 329-36.
16. Chardes T., Villard S., Ferrieres G., Piechaczyk M., Cerutti M., Devauchelle G. et al. (1991) Efficient amplification and direct sequencing of mouse variable regions from any immunoglobulin gene family. FEBS Lett 452: 386-94.
17. Delassus S., Gey A., Darche S., Cumano A., Roth C., Kourilsky P. (1995) PCR-based analysis of the murine immunoglobulin heavy-chain repertoire. J Immunol Meth 184: 219-29.
18. Wang Z., Raifu M., Howard M., Smith L., Hansen D., Goldsby R. et al. (2000) Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3' to 5' exonuclease activity. J Immunol Meth 233: 167-77.
19. Wang J., Villeneuve S., Zhang J., Lei P., Miller C.E., Lafaye P. et al. (1998) On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba. J Biol Chem273: 2777-83.
20. Boutonnier A., Dassy B., Dumenil R., Guenole A., Ratsitorahina M., Migliani R. et al. (2003) A simple and convenient microtiter plate assay for the detection of bactericidal antibodies to Vibrio cholerae O1 and Vibrio cholerae O139. J Microbiol Meth 55: 745-53.
21. Klose K.E. (2000) The suckling mouse model of cholera. Trends Microbiol 8: 189-91.
22. Johnston C.M.,Wood A.L., Bolland D.J., Corcoran A.E. (2006) Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. J Immunol 176: 4221-34.
23. Riblet R., Tutter A., Brodeur P. (1986) Polymorphism and evolution of Igh-V gene families. Curr Top Microbiol Immunol 127: 168-72.
24. Villeneuve S., Souchon H., Riottot M.M., Mazie J.C., Lei P., Glaudemans C.P. et al. (2000) Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. Proc Natl Acad Sci (USA) 97: 8433-38.
25. Ahmed F., André-Leroux G., Haouz A., Boutonnier A., Delepierre M., Qadri F. et al. (2008) Crystal structure of a monoclonal antibody directed against an antigenic determinant common to Ogawa and Inaba serotypes of Vibrio cholerae O1. Proteins 70: 284-8.